New Collaboration Agreement for the Production of Ultra High-Field 7.0-T MRI Systems
By MedImaging International staff writers Posted on 20 May 2015 |
GE Healthcare (Chalfont St. Giles, UK) and Tesla Engineering (Pulborough; England) have announced that they will collaborate to produce 7.0-T human whole-body Magnetic Resonance Imaging (MRI) scanners.
Tesla Engineering, a cryogenics technology company, designs and manufactures resistive and superconducting electromagnets, and will build the 7.0-T magnets in a new factory under construction in Storrington (UK). The company plans to ship the first 7.0-T unit to GE Healthcare in late 2015.
Researchers use the ultra-high-field MRI scanners for scientific and medical research, especially for brain imaging. The research is intended to contribute to earlier detection, better diagnosis, and improved effectiveness for many medical disorders and diseases.
Richard Hausmann, president and CEO of GE Healthcare, said, “This agreement will enable GE to deepen and broaden our collaborations with leading MRI academics and visionaries, sharing our collective expertise and missions in technology, science and medicine. The GE 7.0-T community in the US, Europe and Asia has already demonstrated breakthrough observations and understanding of Alzheimer’s disease, traumatic brain injury and cognitive physiology. Together, we will continue to push the frontiers of MRI for neuroscience and other applications.”
Related Links:
GE Healthcare
Tesla Engineering
Tesla Engineering, a cryogenics technology company, designs and manufactures resistive and superconducting electromagnets, and will build the 7.0-T magnets in a new factory under construction in Storrington (UK). The company plans to ship the first 7.0-T unit to GE Healthcare in late 2015.
Researchers use the ultra-high-field MRI scanners for scientific and medical research, especially for brain imaging. The research is intended to contribute to earlier detection, better diagnosis, and improved effectiveness for many medical disorders and diseases.
Richard Hausmann, president and CEO of GE Healthcare, said, “This agreement will enable GE to deepen and broaden our collaborations with leading MRI academics and visionaries, sharing our collective expertise and missions in technology, science and medicine. The GE 7.0-T community in the US, Europe and Asia has already demonstrated breakthrough observations and understanding of Alzheimer’s disease, traumatic brain injury and cognitive physiology. Together, we will continue to push the frontiers of MRI for neuroscience and other applications.”
Related Links:
GE Healthcare
Tesla Engineering
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer